Oruka Therapeutics (ORKA) Cash from Operations (QoQ) (2010 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn |
| 10 | Oruka Therapeutics | 3.04 Bn | 2.65 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -4.28% |
| Dec 31, 2025 | -4.68% |
| Sep 30, 2025 | 6.62% |
| Jun 30, 2025 | -10.84% |
| Mar 31, 2025 | -10.90% |
| Dec 31, 2024 | 32.35% |
| Sep 30, 2024 | -152.13% |
| Jun 30, 2024 | -6,467.26% |
| Mar 31, 2024 | 84.09% |
| Dec 31, 2023 | 36.73% |
| Sep 30, 2023 | -140.49% |
| Jun 30, 2023 | 56.49% |
| Mar 31, 2023 | -6.76% |
| Dec 31, 2022 | 40.19% |
| Sep 30, 2022 | 4.73% |
| Jun 30, 2022 | 38.99% |
| Mar 31, 2022 | 13.12% |
| Dec 31, 2021 | -1.58% |
| Sep 30, 2021 | -30.91% |
| Jun 30, 2021 | 28.80% |
| Mar 31, 2021 | -74.46% |
| Dec 31, 2020 | -49.60% |
| Sep 30, 2020 | -92.13% |
| Jun 30, 2020 | 38.20% |
| Mar 31, 2020 | -45.60% |
| Dec 31, 2019 | -30.55% |
| Sep 30, 2019 | 25.46% |
| Jun 30, 2019 | 24.01% |
| Mar 31, 2019 | -16.60% |
| Dec 31, 2018 | 14.78% |
| Sep 30, 2018 | 30.08% |
| Jun 30, 2018 | 26.60% |
| Mar 31, 2018 | 26.81% |
| Dec 31, 2017 | -5.59% |
| Sep 30, 2017 | 19.85% |
| Jun 30, 2017 | -14.13% |
| Mar 31, 2017 | -13.07% |
| Dec 31, 2016 | -2.84% |
| Sep 30, 2016 | -5.96% |
| Jun 30, 2016 | 9.19% |
| Mar 31, 2016 | -48.21% |
| Dec 31, 2015 | -9.08% |
| Sep 30, 2015 | -0.13% |
| Jun 30, 2015 | 22.94% |
| Mar 31, 2015 | -65.67% |
| Dec 31, 2014 | 9.53% |
| Sep 30, 2014 | -17.81% |
| Jun 30, 2014 | 52.18% |
| Mar 31, 2014 | -96.96% |
| Dec 31, 2013 | -11.69% |
| Sep 30, 2013 | -71.72% |
| Jun 30, 2013 | -27.75% |
| Mar 31, 2013 | -14.03% |
| Dec 31, 2012 | 13.55% |
| Sep 30, 2012 | 20.68% |
| Jun 30, 2012 | 41.00% |
| Mar 31, 2012 | -33.98% |
| Dec 31, 2011 | 26.25% |
| Sep 30, 2011 | 20.46% |
| Jun 30, 2011 | -8.61% |
| Mar 31, 2011 | -69.88% |
| Dec 31, 2010 | 43.24% |